IRIS

TOMELLERI, ALESSANDRO

TOMELLERI, ALESSANDRO  

Facoltà di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 59 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 1-gen-2021 Campochiaro, C.; Tomelleri, A.; Sartorelli, S.; Sembenini, C.; Papa, M.; Fallanca, F.; Picchio, M.; Cavalli, G.; De Cobelli, F.; Baldissera, E.; Dagna, L.
An enlightening scan 1-gen-2015 Canziani, L.; Tomelleri, A.; Cavalli, G.
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 1-gen-2023 Campochiaro, C.; Farina, N.; Luca, De; Trignani, G.; Tomelleri, A.; Matucci-Cerinic, M.; Dagna, L.
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 1-gen-2022 Campochiaro, C.; Farina, N.; Tomelleri, A.; Ferrara, R.; Viola, S.; Lazzari, C.; De Luca, G.; Raggi, D.; Bulotta, A.; Matucci-Cerinic, M.; Necchi, A.; Garassino, M.; Gregorc, V.; Dagna, L.
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 1-gen-2021 Tomelleri, A.; Campochiaro, C.; De Luca, Giacomo.; Farina, N.; Cavalli, G.; Dagna, L.
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 1-gen-2023 Palmisano, Anna; Vignale, Davide; Bruno, Elisa; Peretto, Giovanni; De Luca, Giacomo; Campochiaro, Corrado; Tomelleri, Alessandro; Agricola, Eustachio; Montorfano, Matteo; Esposito, Antonio
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 1-gen-2023 Palmisano, Anna; Campochiaro, Corrado; Vignale, Davide; Tomelleri, Alessandro; De Luca, Giacomo; Bruno, Elisa; Monti, Caterina B; Cavalli, Giulio; Dagna, Lorenzo; Esposito, Antonio
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 1-gen-2024 Diral, E.; Campochiaro, C.; Tomelleri, A.; Bergonzi, G. M.; Pizzano, U.; Ponzoni, M.; Bongiovanni, L.; Ronchi, P.; Tresoldi, C.; Rigamonti, S.; Scarfo, F.; Latino, G. M.; Rinaldi, E.; Bernardi, M.; Dagna, L.; Ciceri, F.
Clinical and dermoscopic description of accelerated nodulosis after tocilizumab treatment for an isolated aortitis with coronary involvement 1-gen-2021 Paolino, G.; Sartorelli, S.; Rizzo, N.; Tomelleri, A.; Campochiaro, C.; Pampena, R.; Dagna, L.; Mercuri, S. R.
Clinically isolated aortitis successfully treated with methotrexate monotherapy 1-gen-2020 Sartorelli, S.; Tomelleri, A.; Palmisano, A.; Vignale, D.; Esposito, A.; Dagna, L.; Campochiaro, C.
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 1-gen-2021 Campochiaro, C.; Tomelleri, A.; Sartorelli, S.; Cavalli, G.; De Luca, G.; Baldissera, E.; Dagna, L.
Drug retention rates of biological agents in adult onset Still's disease 1-gen-2021 Campochiaro, C.; Farina, N.; Tomelleri, A.; De Luca, Giacomo.; Baldissera, E.; Cavalli, G.; Dagna, L.
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 1-gen-2020 Farina, N; Tomelleri, A; Campochiaro, C; De Luca, G; Cavalli, G; Baldissera, E; Dagna, L
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 1-gen-2022 Tomelleri, A; Campochiaro, C; Sartorelli, S; Baldassi, F; Fallanca, F; Picchio, M; Baldissera, E; Dagna, L
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 1-gen-2023 Tomelleri, A.; Campochiaro, C.; Farina, N.; Mariotti, L.; Baldissera, E.; Grayson, P. C.; Matucci-Cerinic, M.; Dagna, L.
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 1-gen-2022 Campochiaro, C.; Cavalli, G.; Farina, N.; Tomelleri, A.; De Luca, G.; Dagna, L.
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 1-gen-2019 De Luca, Giacomo; Cariddi, Adriana; Campochiaro, Corrado; Vanni, Daniele; Boffini, Nicola; Tomelleri, Alessandro; Cavalli, Giulio; Dagna, Lorenzo
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 1-gen-2021 Campochiaro, Corrado; De Luca, Giacomo; Sartorelli, Silvia; Tomelleri, Alessandro; Esposito, Antonio; Candela, Caterina; Cavalli, Giulio; Dagna, Lorenzo
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients 1-gen-2022 Mekinian, A.; Biard, L.; Dagna, L.; Novikov, P.; Salvarani, C.; Espitia, O.; Sciascia, S.; Michaud, M.; Lambert, M.; Hernandez-Rodriguez, J.; Schleinitz, N.; Awisat, A.; Puechal, X.; Aouba, A.; Munoz Pons, H.; Smitienko, I.; Gaultier, J. B.; Le Mouel, E.; Benhamou, Y.; Perlat, A.; Jego, P.; Goulenok, T.; Sacre, K.; Lioger, B.; Hassold, N.; Broner, J.; Dufrost, V.; Sene, T.; Seguier, J.; Maurier, F.; Berthier, S.; Belot, A.; Frikha, F.; Denis, G.; Audemard-Verger, A.; Kone Pault, I.; Humbert, S.; Woaye-Hune, P.; Tomelleri, A.; Baldissera, E.; Kuwana, M.; Lo Gullo, A.; Gaches, F.; Zeminsky, P.; Galli, E.; Alvarado, M.; Boiardi, L.; Muratore, F.; Vautier, M.; Campochiaro, C.; Moiseev, S.; Cacoub, P.; Fain, O.; Saadoun, D.
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 1-gen-2020 Campochiaro, C.; Della-Torre, E.; Cavalli, G.; De Luca, G.; Ripa, M.; Boffini, N.; Tomelleri, A.; Baldissera, E.; Rovere-Querini, P.; Ruggeri, A.; Monti, G.; De Cobelli, F.; Zangrillo, A.; Tresoldi, M.; Castagna, A.; Dagna, L (TOCI-RAF Study Group); Landoni, G; DELLA TORRE, Emanuel